Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Zymeworks Inc. (ZYME)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
6.86+0.13 (+1.93%)
At close: 04:00PM EDT
6.86 0.00 (0.00%)
After hours: 06:23PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Performance Outlook
Previous Close6.73
Open6.87
Bid5.35 x 1400
Ask7.27 x 800
Day's Range6.72 - 6.95
52 Week Range4.56 - 37.19
Volume438,354
Avg. Volume1,154,653
Market Cap397.145M
Beta (5Y Monthly)1.13
PE Ratio (TTM)N/A
EPS (TTM)-4.97
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ZYME

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zymeworks Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    15 hours agoArgus Research
View more
Advertisement
Advertisement